PATENT CLAIM ANALYSIS

Application Number: 15885630
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "047000"]

Abstract:
A hemi-sulfate salt of the structure: to treat a host infected with hepatitis C, as well as pharmaceutical compositions and dosage forms, including solid dosage forms, thereof.

Claim (Index 10):
The solid dosage form of  claim 7 , wherein the area under the curve is between approximately 2,400 ng*h/mL and 3,000 ng*h/mL.

Metadata:
- Claim Count in Document: 131.0
- Percentile: 86.0
- Lexical Diversity: 1.18519
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14252290', '15782628', '10607909', '11516928', '15744094']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7605189128022787
- 35 USC 102 Novelty (BERT): 0.5215599157722614
- Combined Prediction Score: 0.736623013099277
- Mean Citation Score: 250.91714399999995
- Max Citation Score: 261.86374
- Similarity Product: 153.92419992971898

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test